Skip to main content
Log in

Systemic sclerosis in the elderly

  • Originals
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Summary

In our study, the characteristics of 114 patients with systemic sclerosis (SSc) are discussed with emphasis on the subgroup of cases whose onset of disease occurred above the age of 60 years. Seven out of the 9 cases showed symptoms of diffuse cutaneous systemic sclerosis with an extensive skin involvement, and 5 of these cases died within 2 years following the onset of SSc. Seven of the 9 cases showed a rapid disease course with symptoms of cardiac, pulmonary and/or renal involvement, while no secondary Sjögren's syndrome, subcutaneous calcinosis and myositis were demonstrated among these patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Czirják, L., Schlammadinger, J., Szegedi, G. Anticentromere antibody and Raynaud phenomenon. Dermatologica 1991, 183, 55.

    Article  PubMed  Google Scholar 

  2. Czirják, L., Bokk, Á., Csontos, G., Lörincz, G., Szegedi, G. Clinical findings in patients with progressive systemic sclerosis. Acta Derm Venereol (Stockh.) 1989, 69, 533–36.

    Google Scholar 

  3. Lally, E.V., Jimenez, S.A., Kaplan, S.R. Progressive systemic sclerosis: mode of presentation, rapidly progressive disease course, and mortality based on an analysis of 91 patients. Semin Arthritis Rheum 1988, 18, 1–13.

    Article  CAS  PubMed  Google Scholar 

  4. Subcommittee for scleroderma. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980, 23, 581–590.

    Article  Google Scholar 

  5. LeRoy, C.E., Krieg, T., Black, C., Medsger, T.A.Jr., Fleischmajer, R., Rowell, N., Jablonska, S., Wollheim, F. Scleroderma (systemic sclerosis): Classification, subsets and pathogenesis (editorial). J Rheumatol 1988, 15, 202–205.

    CAS  PubMed  Google Scholar 

  6. Tamási, L., Dézsi, Á., Sonkoly, I., Kiss, E., Balázs, C., Szegedi, G. Examination of the epidemiology of immunopathological diseases in inhabitats of Hajdu-Bihar county (abstract in English). Orvosi Hetilap 1987, 128, 2101–2105.

    PubMed  Google Scholar 

  7. Medsger, T.A., Masi, A.T., Rodnan, G.P., Benedek, T.G., Robinson. Survival with systemic sclerosis (scleroderma): A lifetable analysis of clinical and demographic factors in 309 patients. Ann Intern Med 1971, 75, 369–37.

    Article  PubMed  Google Scholar 

  8. Wynn, J., Fineberg, N., Matzer, L., Cortada, X., Armstrong, W., Dillon, C., Kinney, E. Prediction of survival in progressive systemic sclerosis by multivariate analysis of clinical features. Am Heart J 1985, 110, 123–12.

    Article  CAS  PubMed  Google Scholar 

  9. Barnett, A.J. Scleroderma (Progressive systemic sclerosis): Progress and course based on a personal series of 118 cases Med J Aust 1978, 2, 129–134.

    CAS  PubMed  Google Scholar 

  10. Bennett, R., Bluestone, R., Holt, P.J.L., Bywaters, E.G.L. Survival in scleroderma. Ann Rheum Dis 1971, 30, 581–588.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  11. Medsger, T.A., Masi, A.T. Survival with scleroderma. II: A lifetable analysis of clinical and demographic factors in 358 male US veteran patients. J Chron Dis 1973, 26, 647–660.

    Article  PubMed  Google Scholar 

  12. Norton, W.L., Nardo, J.M. Vascular disease in progressive systemic sclerosis (scleroderma). Ann Intern Med 1970, 73, 317–324.

    Article  CAS  PubMed  Google Scholar 

  13. Rodnan, G.P. Progressive systemic sclerosis: Clinical features and pathogenesis of cutaneous involvement scleroderma. Clin Rheum Dis 1979, 5, 49–7.

    Google Scholar 

  14. Medsger, T.A. Jr., Masi, A.T. Epidemiology of systemic sclerosis (scleroderma) among US male veterans J Chron Dis 1978, 31, 73–85.

    Article  PubMed  Google Scholar 

  15. Leinwand, I., Duryee, A.S., Richter, M.N. Scleroderma (based on a study of over 150 cases). Ann Intern Med 1954, 41, 1003–1041.

    Article  CAS  PubMed  Google Scholar 

  16. Farmer, R.G., Gifford, R.W., Hines E.A. Prognostic significance of Raynaud's phenomenon and other clinical characteristics of systemic scleroderma: A study of 271 cases. Circulation 1960, 21, 1088–1095.

    Article  CAS  PubMed  Google Scholar 

  17. Peters-Golden, M., Wise, R.A., Hochberg, M.C., Stevens, M.B., Wigley, F. Carbon monoxide diffusing capacity as predictor of outcome in systemic sclerosis. Am J Med 1984, 77, 1027–1034.

    Article  CAS  PubMed  Google Scholar 

  18. Catoggio, L.J., Bernstein, R.M., Black, C.M., Hughes, G.R.V., Maddison, P.J., Serological markers in progressive systemic sclerosis. Clinical correlations. Ann Rheum Dis 1983, 42, 23–27.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  19. Tuffanelli, D.L., Winkelmann, R.K. Systemic scleroderma: A clinical study of 727 cases. Arch Dermatol 1961, 84, 359–371.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Czirják, L., Nagy, Z. & Szegedi, G. Systemic sclerosis in the elderly. Clin Rheumatol 11, 483–485 (1992). https://doi.org/10.1007/BF02283102

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02283102

Key words

Navigation